VENTANA pan-TRK (EPR17341) Assay
Aug 12, 2019
The VENTANA pan-TRK (EPR17341) Assay:
- The first assay of its type to detect tropomyosin receptor kinase (TRK) with anticipated use across multiple solid tumour types.
- The assay is expected to provide improved data on the prevalence of TRK proteins in tumour tissue studies.
- The significance of TRK fusion proteins is currently being investigated in various cancer indications
This product is intended for in vitro diagnostic (IVD)